NOVARTIND — Novartis India Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual income statement for Novartis India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,999	3,787	3,351	3,563	3,543
Cost of Revenue
Gross Profit	2,184	1,741	1,327	1,506	1,560
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,319	3,187	2,722	2,662	2,622
Operating Profit	-320	601	629	901	922
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-38.2	1,154	1,228	1,304	1,297
Provision for Income Taxes
Net Income After Taxes	-37.2	1,034	852	1,009	932
Net Income Before Extraordinary Items
Net Income	-37.2	1,034	852	1,009	932
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-37.2	1,034	852	1,009	932
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	11.6	40.8	32.8	40.8	37.7
Dividends per Share
Special Dividends per Share